Vimergy Launches the “Mouth of America” – Exposing a System That Profits When We Stay Sick

New National Campaign Confronts the Healthcare Industry's Perverse Incentives and Sparks a Movement for Preventive Wellness

Vimergy, the premium supplement company helping people reclaim their health with pure, potent, and timeless products, today launched the “Mouth of America” – an immersive national campaign debuting a large-scale art installation in New York City. Designed to provoke and inspire, the campaign calls attention to America's real health crisis: chronic, system-driven illness fueled by a healthcare model that profits when we stay sick. This problem shows no sign of abating: In 2024, Americans collectively took 215 billion doses of prescription medication.

https://mma.prnewswire.com/media/2690976/Vimergy_Lady_Libertys_Mouth_of_America.jpg

At the heart of the campaign is a striking public sculpture: Lady Liberty's Mouth of America. In this provocative installation, the face of the Statue of Liberty appears to ingest hundreds of giant pills scattered across the pavement. A universal symbol of freedom and hope, Lady Liberty now stands as a powerful metaphor for a nation drowning in chronic illness, overmedication, and growing distrust in the institutions meant to protect us.

“This installation challenges the narrative we've long been sold – that our system is built to keep us healthy,” said Phil Jacobson, Chief Brand and Marketing Officer of Vimergy. “But the truth is, the sicker we are, the more the system profits. Lady Liberty has become a patient herself – and she's not alone.”

The “Mouth of America” reflects the fact that in 2022, there were 6.7 billion total annual prescriptions in the U.S. alone. With this level of overprescription and still so much chronic illness, we have to ask: Who's really benefiting from keeping us sick?

By grounding abstract data in something so innately representative of America, the installation reminds us that well-being doesn't start in a lab or a pharmacy. It starts with our choices.

Today, Vimergy also launched wecansaveourselves.com, a new campaign website that features a short film produced in partnership with Uncommon Creative Studio, a national survey of health and wellness consumers conducted by Talker Research, and educational materials about root-cause issues and health sovereignty.

“The name says it all – we can save ourselves,” added Dani Frese, Vimergy Wellness Consultant. “Americans are ready to break free from a system that treats symptoms, not people. This campaign is a rallying cry.”

The campaign sets the tone for the company's broader movement and its hopeful call to reclaim health on our own terms, one drop, one dose, one decision at a time. Vimergy was born out of its founders' personal journeys to resist chronic illness and reclaim vitality through nutrition, supplementation, and self-advocacy. Today, Vimergy products are trusted by health seekers in over 60 countries.

You will soon be able to find Lady Liberty in a city near you. For updates, locations, and video content, visit wecansaveourselves.com.

About VimergyVimergyis a premium supplement company offering pure, potent, and timeless products to help people reclaim their health and future. Our supplements are consciously crafted to empower people to feel better, think clearer, and be at their best. All Vimergy products are Non-GMO, Gluten-Free, Soy-Free, and Paleo Friendly. Vimergy is also a leader in the liquid vitamins space, providing people with a fast-acting, gut-friendly option for supplementing their diet without resorting to more pills. In an era of symptom-chasing and overprescription, we are empowering people to feel their best on their terms – one drop, one dose, one decision at a time.

CONTACT INFO:press@vimergy.com

https://c212.net/c/img/favicon.png?sn=NY90625&sd=2025-05-19

View original content to download multimedia:https://www.prnewswire.com/news-releases/vimergy-launches-the-mouth-of-america–exposing-a-system-that-profits-when-we-stay-sick-302459365.html

SOURCE Vimergy

https://rt.newswire.ca/rt.gif?NewsItemId=NY90625&Transmission_Id=202505191341PR_NEWS_USPR_____NY90625&DateId=20250519

Scroll to Top